These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 20641320

  • 1.
    Cheng KT.
    ; 2004. PubMed ID: 20641320
    [Abstract] [Full Text] [Related]

  • 2.
    Cheng KT.
    ; 2004. PubMed ID: 20641585
    [Abstract] [Full Text] [Related]

  • 3.
    Cheng KT.
    ; 2004. PubMed ID: 20641775
    [Abstract] [Full Text] [Related]

  • 4.
    Cheng KT.
    ; 2004. PubMed ID: 20641580
    [Abstract] [Full Text] [Related]

  • 5.
    Cheng KT.
    ; 2004. PubMed ID: 20641456
    [Abstract] [Full Text] [Related]

  • 6.
    Cheng KT.
    ; 2004. PubMed ID: 20641734
    [Abstract] [Full Text] [Related]

  • 7.
    Cheng KT.
    ; 2004. PubMed ID: 20641718
    [Abstract] [Full Text] [Related]

  • 8.
    Cheng KT.
    ; 2004. PubMed ID: 20641631
    [Abstract] [Full Text] [Related]

  • 9.
    Cheng KT.
    ; 2004. PubMed ID: 20641419
    [Abstract] [Full Text] [Related]

  • 10. A CDR-grafted (humanized) domain-deleted antitumor antibody.
    Slavin-Chiorini DC, Kashmiri SV, Lee HS, Milenic DE, Poole DJ, Bernon E, Schlom J, Hand PH.
    Cancer Biother Radiopharm; 1997 Oct; 12(5):305-16. PubMed ID: 10851481
    [Abstract] [Full Text] [Related]

  • 11.
    Chopra A.
    ; 2004 Oct. PubMed ID: 22049576
    [Abstract] [Full Text] [Related]

  • 12.
    Cheng KT.
    ; 2004 Oct. PubMed ID: 20641754
    [Abstract] [Full Text] [Related]

  • 13. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
    Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ.
    Cancer Biother Radiopharm; 2005 Oct; 20(5):502-13. PubMed ID: 16248766
    [Abstract] [Full Text] [Related]

  • 15. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, Schlom J.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [Abstract] [Full Text] [Related]

  • 16. Single-chain antibodies in pancreatic cancer.
    Colcher D, Pavlinkova G, Beresford G, Booth BJ, Batra SK.
    Ann N Y Acad Sci; 1999 Jun 30; 880():263-80. PubMed ID: 10415872
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
    Pavlinkova G, Beresford GW, Booth BJ, Batra SK, Colcher D.
    J Nucl Med; 1999 Sep 30; 40(9):1536-46. PubMed ID: 10492377
    [Abstract] [Full Text] [Related]

  • 18.
    Cheng KT.
    ; 2004 Sep 30. PubMed ID: 20641898
    [Abstract] [Full Text] [Related]

  • 19. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A, Khazaeli MB, Safavy K, Mayo MS, Buchsbaum DJ.
    Clin Cancer Res; 1999 Oct 30; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [Abstract] [Full Text] [Related]

  • 20.
    Chopra A.
    ; 2004 Oct 30. PubMed ID: 22741182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.